1. Home
  2. MLEC vs RNXT Comparison

MLEC vs RNXT Comparison

Compare MLEC & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Moolec Science SA

MLEC

Moolec Science SA

HOLD

Current Price

$5.55

Market Cap

5.0M

Sector

Finance

ML Signal

HOLD

Logo RenovoRx Inc.

RNXT

RenovoRx Inc.

HOLD

Current Price

$1.69

Market Cap

79.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLEC
RNXT
Founded
2008
2012
Country
Cayman Islands
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0M
79.4M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
MLEC
RNXT
Price
$5.55
$1.69
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.25
AVG Volume (30 Days)
18.2K
1.4M
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
20.00
EPS
N/A
N/A
Revenue
N/A
$1,123,000.00
Revenue This Year
$20.42
$194.66
Revenue Next Year
$30.00
$279.78
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2511.63
52 Week Low
$0.21
$0.70
52 Week High
$23.22
$2.59

Technical Indicators

Market Signals
Indicator
MLEC
RNXT
Relative Strength Index (RSI) N/A 50.72
Support Level N/A $0.83
Resistance Level N/A $2.59
Average True Range (ATR) 0.00 0.23
MACD 0.00 -0.06
Stochastic Oscillator 0.00 12.02

Price Performance

Historical Comparison
MLEC
RNXT

About MLEC Moolec Science SA

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline, such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's maximum revenues from operations in Argentina.

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: